<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Behav Brain Funct</journal-id><journal-title>Behavioral and Brain Functions</journal-title><issn pub-type="epub">1744-9081</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1744-9081-2-7</article-id><article-id pub-id-type="pmid">16504134</article-id><article-id pub-id-type="doi">10.1186/1744-9081-2-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>The C(-1019)G 5-HT1A promoter polymorphism and personality traits: no evidence for significant association in alcoholic patients</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Koller</surname><given-names>G</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>gabi.koller@med.uni-muenchen.de</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Bondy</surname><given-names>B</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>brigitta.bondy@med.uni-muenchen.de</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Preuss</surname><given-names>UW</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>ulrich_preuss@hotmail.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Zill</surname><given-names>P</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>peter.zill@med.uni-muenchen.de</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Soyka</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>michael.soyka@med.uni-muenchen.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Psychiatrische Klinik der LMU, Substitutionsambulanz, Pestalozzistra&#x000df;e 2, D-80469 M&#x000fc;nchen, Germany</aff><aff id="I2"><label>2</label>Psychiatrische Klinik der LMU, Neurochemie, Nu&#x000df;baumstra&#x000df;e 7, D-80336 M&#x000fc;nchen, Germany</aff><aff id="I3"><label>3</label>Johanna-Odebrecht-Stiftung, G&#x000fc;tzkower Landstra&#x000df;e 69, D-17489 Greifswald, Germany</aff><aff id="I4"><label>4</label>Psychiatrische Klinik der LMU, Nussbaumstrasse 7, D-80336 M&#x000fc;nchen, Germany</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>25</day><month>2</month><year>2006</year></pub-date><volume>2</volume><fpage>7</fpage><lpage>7</lpage><ext-link ext-link-type="uri" xlink:href="http://www.behavioralandbrainfunctions.com/content/2/1/7"/><history><date date-type="received"><day>31</day><month>10</month><year>2005</year></date><date date-type="accepted"><day>25</day><month>2</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 Koller et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Koller et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Koller G gabi.koller@med.uni-muenchen.de </dc:author><dc:title> The C(-1019)G 5-HT1A promoter polymorphism and personality traits: no evidence for significant association in alcoholic patients </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>Behavioral and Brain Functions 2(1): 7-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1744-9081(2006)2:1&#x0003c;7&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1744-9081</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><p>The 5HT1A receptor is one of at least 14 different receptors for serotonin which has a role in moderating several brain functions and may be involved in the aetiology of several psychiatric disorders. The C(-1019)G 5-HT1A promoter polymorphism was reported to be associated with major depression, depression-related personality traits and suicidal behavior in various samples. The G(-1019) allele carriers are prone to depressive personality traits and suicidal behavior, because serotonergic neurotransmission is reduced.</p><p>The aim of this study is to replicate previous findings in a sample of 185 Alcohol-dependent individuals. Personality traits were evaluated using the NEO FFI and TCI. History of suicidal behavior was assessed by a standardized semistructured interview (SSAGA). No significant differences across C(-1019)G 5-HT1A genotype groups were found for TCI temperament and character traits and for NEO FFI personality scales. No association was detected between this genetic variant and history of suicide attempts. These results neither support a role of C(-1019)G 5-HT1A promoter polymorphism in the disposition of personality traits like harm avoidance or neuroticism, nor confirm previous research reporting an involvement of the G allele in suicidal behavior in alcoholics. Significant associations, however, were detected between Babor's Type B with number of suicide attempts in history, high neuroticism and harm avoidance scores in alcoholics.</p></abstract></article-meta></front><body><sec><title>Background</title><p>The 5-hydroxytryptamine 1A receptor (5-HT1A) is one of several different receptors for 5-hydroxytryptamine (serotonin). Serotonin has a role in moderating several brain functions and is involved in the aetiology of several psychiatric disorders. Evidence for a role of 5-HT1A receptor in the pathophysiology of anxiety and depression has come from several clinical studies as well as from animal models [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. In animal models, 5-HT1A receptor-deficient animals have been reported to have an increased level of anxiety and stress response as well as decreased exploratory activity [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. The 5-HT1A receptor is also suggested to be involved in the response to antidepressant and anxiolytic drugs [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>].</p><p>The 5-HT1A receptor is an integral membrane protein and belongs to the family of G-protein coupled receptors that inhibit adenylate cyclase activity. Negative feedback inhibition of serotonergic raphe neurons is mediated by somatodendritic 5-HT1A autoreceptors [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. Reduced serotonergic neurotransmission is implicated in the pathogenesis of depressive illness and suicidal behaviors [<xref ref-type="bibr" rid="B10">10</xref>]. The gene for the 5-HT1A receptor is located at chromosomal region 5q11.2-q13 [<xref ref-type="bibr" rid="B11">11</xref>]. Human 5-HT1A gene transcription is modulated by a common C(-1019)G single nucleotide polymorphism (SNP) in its upstream regulatory region. The C(-1019) allele is part of a 26 bp imperfect palindrome that binds transcription factors NUDR (nuclear deformed epidermal auto regulatory factor) whereas the G(-1019) allele abolishes repression by NUDR, but only partially impairs Hes5-mediated repression. It was suggested that the G(-1019) allele derepresses 5-HT1A auto receptor expressions to reduce serotonergic neurotransmission [<xref ref-type="bibr" rid="B12">12</xref>].</p><p>Previous studies reported an association of the C(-1019)G 5-HT1A-promoter polymorphism with major depression and suicide in a number of samples.</p><p>There is a close relationship between the diagnosis depression and certain personality traits. The personality characteristic neuroticism and the temperament trait harm avoidance seem to be most interesting in this field. Neuroticism is described to be related with anxiety and depression [<xref ref-type="bibr" rid="B13">13</xref>]. Regarding temperament traits, harm avoidance have also been reported to be associated with anxiety and depression [<xref ref-type="bibr" rid="B14">14</xref>]. As there is a close relationship between character and personality traits to depressive and anxiety symptoms, the role of C(-1019)G 5-HT1A polymorphism in modulating these personality traits was evaluated to investigate the biological underpinnings of these important characteristics.</p><p>A significant effect of the C(-1019)G 5-HT1A polymorphism on neuroticism was detected with carriers of the G allele having higher scores than individuals homozygous for the C nucleotide. Carriers of the G allele also exhibited higher harm avoidance scores than carriers of the C allele [<xref ref-type="bibr" rid="B15">15</xref>].</p><p>Since suicidal behaviour is one of the diagnostic criteria for depression, a relationship between suicidal behavior and 5-HT1A receptor genetic variants can be expected but conflicting results were reported [<xref ref-type="bibr" rid="B16">16</xref>].</p><p>Persistent alterations in neuroendocrine responsiveness of both 5-HT and noradrenergic systems in alcoholic patients are documented [<xref ref-type="bibr" rid="B17">17</xref>]. Thus, an investigation of the influence of C(-1019)G 5-HT1A-promoter polymorphism on anxiety and depression-related personality traits in alcohol-dependent individuals might be of interest.</p><p>This manuscript represents an association study in a new population-German alcoholics. Suicide in a pure alcoholic sample is thought to have similar etiology to suicide in a depression sample.</p><p>The aim of our study is to investigate the C(-1019)G 5-HT1A-promoter polymorphism and its possible association with anxiety and depression-related personality traits and suicidal behavior. We hypothesize a significant effect of the C(-1019)G 5-HT1A polymorphism on neuroticism with carriers of the G allele having higher scores than individuals homozygous for the C variant as well as carriers of the G allele showing higher harm avoidance scores. Furthermore we hypothesize carriers of the G allele showing more suicide attempts in history. Since the severity of alcohol dependence and psychopathology differ in subtypes of alcoholics, potential interactions with Babor's Type A/ B subtypes were also investigatated.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Study design</title><p>From the addiction treatment ward of the psychiatric hospital at the University of Munich, 185 treatment-seeking individuals were recruited. All patients were unrelated, of German descent, older than 18 years and met ICD-10 and DSM-IV criteria for alcohol dependence, assessed with the structured clinical interview DSM IV [<xref ref-type="bibr" rid="B18">18</xref>] and SSAGA (Semi-Structured Assessment on the genetics in alcoholism) [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. The diagnostic assessment was performed without knowledge of genotype data.</p><p>All patients were assessed two weeks after admission and after completing alcohol withdrawal, being free of any psychopharmacologic treatment for an average of 1.5 +0.6 weeks. Alcohol-dependent patients were excluded if they had a history of an independent major psychiatric disorder (occurring before the onset of alcohol dependence or during prolonged periods of abstinence) or substance dependence other than alcohol, marijuana or nicotine.</p><p>Informed written consent was obtained from patients after complete and extensive description of the study. The study was approved by the ethical committee of the Ludwig-Maximilians University of Munich in agreement with the principles laid down in the Helsinki Declaration (1964).</p><p>All participants completed the German version of Neo FFI and TCI [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. The NEO Five-Factor Inventory is a shortened version of the NEO-PI, designed to give quick, reliable and valid measures of the five domains of adult personality including Neuroticism, Openness, Extraversion, Agreeableness and Consciousness. The 60 items are rated on a five-point scale. The NEO-FFI has a grade six reading level, and requires 10&#x02013;15 minutes to complete [<xref ref-type="bibr" rid="B23">23</xref>]. The Temperament and Character Inventory (TCI) is a self-rating questionnaire designed to quantify individual differences on each of the temperament (Harm avoidance, Novelty seeking, Reward dependence and character dimension (Resistance, Self-directedness, Cooperation, Self-transcendence) [<xref ref-type="bibr" rid="B24">24</xref>]. Diagnostic and sampling procedure and research instruments were also described in previous publications [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>].</p><p>Withdrawal symptomatology as well as a history of suicide attempts were evaluated using the SSAGA (Semi-Structured Assessment on the genetics in alcoholism [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>].</p><p>Alcohol-dependent patients were classified as Type A or Type B using Babor Typology [<xref ref-type="bibr" rid="B27">27</xref>], using the criteria of Schuckit [<xref ref-type="bibr" rid="B28">28</xref>]. Characteristics of alcohol dependence, including the five characteristics mentioned by Schuckit were assessed using the SSAGA. These characteristics included daily alcohol intake (drinks of alcohol per drinking day (g/d), relief drinking, medical conditions due to alcohol, and physical and social consequences. Taking SSAGA data, composite scales were calculated for the five characteristics and dichotomised using median split. The 5 items were normalized prior to creating a composite scale. Subjects were subtyped according to Type A or B if they met three or more of the dichotomised scores criteria (upper half: Type B, lower half Type A).</p></sec><sec><title>Genotyping</title><p>Genomic DNA was isolated from whole blood according to standard procedures. All genotyping was performed with the fluorescence resonance energy transfer method (FRET) using the Light Cycler System (Roche Diagnostics, Mannheim, Germany). A detailed description of the theoretical background and methodology is given [<xref ref-type="bibr" rid="B29">29</xref>]. For the C-1019G polymorphism in the 5HT1A receptor gene the following conditions were applied. Forward primer: 5'-CCG TTT TGT TGT TGT TGT CG-3'; reverse primer: 5'-CCA GCA AAA CTG GGG TTG3'; donor hybridization probe: 5'-TTT AAA AAC GAA GAC ACA CTC-fluorescein-3'; acceptor hybridization probe:</p><p>5'-LCRed640-CTT CTT CCA TCA ATT AGC AAT AAT TGG GAG-3'. PCR was performed with 50 ng DNA in a total volume of 20 &#x003bc;l containing 2 &#x003bc;l reaction mix, 0.5 &#x003bc;M each primer, 0.2 &#x003bc;M each hybridization probe and 2 &#x003bc;M MgCl<sub>2 </sub>according to the manufacturer's instructions for 35 cycles of denaturation (95&#x000b0;C, 0 s, ramp rate 20&#x000b0;C/s), annealing (55%&#x000b0;C, 10 s, ramp rate 20&#x000b0;C/s) and extension (72&#x000b0;C, 10 s, ramp rate 20&#x000b0;C/s). After amplification a melting curve was generated by holding the reaction at 40&#x000b0;C for 20 s and then heating slowly to 95&#x000b0;C with a ramp rate of 0.2&#x000b0;C/s. The fluorescence signal was plotted against temperature to give melting curves for each sample. Peaks were obtained at 57&#x000b0;C for the C-allele and at 46&#x000b0;C for the G-allele. All laboratory procedures were carried out blind to diagnostic assessment.</p></sec><sec><title>Statistical analyses</title><p>To analyze relationships between personality traits and suicidal behavior with 5-HT1A genotypes and subtypes of alcoholics in a single model, a single MANOVA (multivariate analysis of variance) was performed. Suicide attempts in history, neuroticism and harm avoidance were used as dependent variables, C(-1019)G 5-HT1A and Babor Typology were used as independent factors. A p-value of &#x0003c;0.05 (2-tailed) was considered as statistically significant.</p></sec></sec><sec><title>Results</title><p>A total of 185 alcohol-dependent individuals were enrolled into the study. Sample characteristics are presented in table <xref ref-type="table" rid="T1">1</xref>.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Sample characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left"><bold>Male</bold></td><td align="left"><bold>Female</bold></td></tr></thead><tbody><tr><td align="left"><bold>Number</bold></td><td align="left">150 (81,1%)</td><td align="left">35 (18.9%)</td></tr><tr><td align="left"><bold>Mean Age</bold></td><td align="left">41.6 &#x000b1; 9,69</td><td align="left">41,5 &#x000b1; 3,56</td></tr><tr><td align="left">Mean age of onset</td><td align="left">28,56 &#x000b1; 8,55</td><td align="left">31,8 &#x000b1; 8,77</td></tr><tr><td align="left">Mean alcohol intake (g per day)</td><td align="left">360,75 &#x000b1; 199,8</td><td align="left">216,15 &#x000b1; 108,33</td></tr><tr><td align="left">Type A</td><td align="left">97 (52,4%)</td><td align="left">25 (13,5%)</td></tr><tr><td align="left">Type B</td><td align="left">53 (28,6%)</td><td align="left">10 (5,5%)</td></tr><tr><td align="left">At last one suicide attempt in history</td><td align="left">31 (16,7%)</td><td align="left">10 (5,4%)</td></tr></tbody></table></table-wrap><p>Using a single MANOVA no significant association was detected between C(-1019)G 5-HT1A and suicide attempt in history (F = 0.230, p = 0.795, df = 2), between C(-1019)G 5-HT1A and neuroticism (F = 0.811, p = 0.446, df = 2) and between C(-1019)G 5-HT1A and harm avoidance (F = 0.268, p = 0.765, df = 2).</p><p>However, significant associations were found between Babor's Type A/B and suicide attempts in history (F = 9.299, p = 0.003, df = 1), neuroticism (F = 9.857, p = 0.002, df = 1) and harm avoidance (F = 5.383, p = 0.022, df = 1). Type B shows higher neuroticism scores, as well as higher harm avoidance scores and a more frequent amount of suicide attempts in history.</p><p>No significant interaction between C(-1019)G 5-HT1A and Babor Typology in suicide attempts (F = 1.220, p = 0.298, df = 2), between C(-1019)G 5-HT1A and Babor Typology and neuroticism (F = 0.763, p = 0.468, df = 2) and between C(-1019)G 5-HT1A and Babor Typology and harm avoidance (F = 0.803, p = 0.450, df = 2) could be detected (s.table <xref ref-type="table" rid="T2">2</xref>).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Total numbers, Means of Neuroticism and Harm avoidance and numbers of patients with suicide attempts in history grouped by GG, GC and CC and by Babor Typology(SD = Standard deviation)</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left"><bold>GG </bold><bold>Type A</bold></td><td align="left"><bold>GG </bold><bold>Type B</bold></td><td align="left"><bold>GC </bold><bold>Type A</bold></td><td align="left"><bold>GC </bold><bold>Type B</bold></td><td align="left"><bold>CC </bold><bold>Type A</bold></td><td align="left"><bold>CC </bold><bold>Type B</bold></td></tr></thead><tbody><tr><td align="left"><bold>Number of patients</bold></td><td align="left">30 (16,2%)</td><td align="left">15 (8,1%)</td><td align="left">62 (33,5%)</td><td align="left">32 (17,2%)</td><td align="left">30 (16,2%)</td><td align="left">16 (8,6%)</td></tr><tr><td align="left"><bold>Neuroticism score (Mean/SD)</bold></td><td align="left">22,6 &#x000b1; 8</td><td align="left">28,2 &#x000b1; 8</td><td align="left">23,3 &#x000b1; 8</td><td align="left">27,3 &#x000b1; 8</td><td align="left">22,1 &#x000b1; 6</td><td align="left">25,1 &#x000b1; 8</td></tr><tr><td align="left"><bold>Harm avoidance score (Mean/SD)</bold></td><td align="left">16,1 &#x000b1; 6</td><td align="left">19,7 &#x000b1; 6</td><td align="left">15,9 &#x000b1; 6</td><td align="left">18,0 &#x000b1; 6</td><td align="left">16,2 &#x000b1; 6</td><td align="left">17,4 &#x000b1; 5</td></tr><tr><td align="left"><bold>Suicide attempts in history </bold><bold>(Number of patients)</bold></td><td align="left">4 (2,1%)</td><td align="left">7 (3,7%)</td><td align="left">11 (5,9%)</td><td align="left">10 (5,4%)</td><td align="left">3 (1,6%)</td><td align="left">6 (3,2%)</td></tr></tbody></table></table-wrap></sec><sec><title>Discussion</title><p>The present study re-examined the potential association of a functional 5-HT1A-receptor polymorphism, a history of suicide attempts, and personality traits of harm avoidance and neuroticism. Our results do not support an association between the C(-1019)G 5-HT1A-promoter polymorphism with these personality and temperament traits, and also failed to detect an association between this functional polymorphism and a history of suicide attempts in 185 alcohol-dependent individuals. Significant associations were found between Babor's Type B and increased number of suicide attempts in history as well as higher neuroticism and harm avoidance scores.</p><p>The only previous study reporting an association between personality traits and this polymorphism in individuals of Caucasian background described the C(-1019)G 5-HT1A promoter polymorphism to be associated with the personality traits harm avoidance and neuroticism [<xref ref-type="bibr" rid="B15">15</xref>]. In accord with our assessments, in this prior study personality traits were assessed by NEO-PIR and TPQ.</p><p>The NEO FFI has five dimensions; their mean and standard deviation reference values in German population were described by authors of the German version [<xref ref-type="bibr" rid="B21">21</xref>]. The scale Harm avoidance is in line with a low score in self-directedness reflecting low responsibility, low purposefulness, low resourcefulness, low self-acceptance and low congruent second nature [<xref ref-type="bibr" rid="B30">30</xref>].</p><p>Thus, the divergent results deserve comments. The conceptual frame of anxiety-and depression-related personality traits and its assessment in alcoholics shortly after alcohol detoxification may be a relevant factor influencing the results.</p><p>The association of the G allele with certain personality traits may be different in subjects affected by other psychiatric disorders. For an association between suicide attempts and C(-1019)G 5-HT1A-promoter polymorphism the power of our sample might be too low (41 individuals reported a history of suicide attempts). Suicidal behaviour in general may be too heterogeneous to be a suitable phenotype to demonstrate genetic influence of single polymorphisms. Another limitation of the study is that participants were drug free only for 1,5 &#x000b1; 0,6 weeks before the study but the 5-HT1A autoreceptor take 2&#x02013;3 weeks to desensitise [<xref ref-type="bibr" rid="B31">31</xref>]. Reinvestigation of the participants after a longer drug free interval could be helpful.</p><p>Furthermore, it is not unusual that results of association studies significantly depend on the assessment method, i.e. the type of questionnaires and tests used. In a recent meta-analysis contrasts between groups were shown to be significant for TCI/TPQ Harm avoidance but not for NEO Neuroticism [<xref ref-type="bibr" rid="B32">32</xref>]. This may indicate more heterogeneity for the phenotype</p><p>Another meta-analysis reported significant effects on 5-HTTLPR. For studies using the Neuroticism scale of Costa and McCrae [<xref ref-type="bibr" rid="B33">33</xref>]. Findings do indicate that the effect, if present, is small.</p><p>There are also effects from other parts of the serotonergic system on the 5-HT1A receptor. In a very recent study it was demonstrated for the first time that a functional polymorphism in the 5-HTT gene, but not the 5-HT1A-receptor gene itself, affects 5-HT1A receptor availability in man. The 5-HT1A-receptor genotype did not show any significant effects on [11C]WAY 100635 binding [<xref ref-type="bibr" rid="B34">34</xref>]. These results may explain our results as far as functional significance is not as predicted.</p><p>Patients with panic disorder and depression exhibit an attenuation of 5-HT1A receptor-mediated neuroendocrine response, reflecting dysfunction of pre and postsynaptic 5-HT1A receptors [<xref ref-type="bibr" rid="B35">35</xref>]. Subsequent studies suggested the same mechanism to be associated with agoraphobia in a group of patients with panic disorders [<xref ref-type="bibr" rid="B36">36</xref>].</p><p>Decreased ligand binding of 5-HT1A receptors has been shown in depressed patients [<xref ref-type="bibr" rid="B37">37</xref>].</p><p>Not much data are available about association of personality traits and C(-1019)G 5-HT1A-promoter polymorphism. Regarding an association between the C(-1019)G 5-HT1A-promoter polymorphism and suicidal behavior, a recent study detected a significant association between this polymorphism and completed suicide [<xref ref-type="bibr" rid="B12">12</xref>]. However, the Pro16Leu and Gly272Asp polymorphisms of the 5-HT1A receptor gene failed to show an association with completed suicide in another study [<xref ref-type="bibr" rid="B38">38</xref>].</p><p>Since not much data are available in this field additional data may provide additional support or fail to support the hypothesis. Use of haplotypes for a particular gene or a broader assessment of serotonergic genes is mentioned as a stronger methodology.</p></sec><sec><title>Conclusion</title><p>In conclusion our data failed to show the previously described association between the C(-1019)G 5-HT1A-promoter polymorphism and certain personality traits, which are depression- and anxiety-related. Our data also do not support an association between C(-1019)G 5-HT1A-promoter polymorphism and a history of suicide attempts. Further studies should address some of the open questions that remain. Another possible issue is whether therapeutic response to serotonergic agents is influenced by this polymorphism. Significant association is shown between Babor's Type B and number of suicide attempts in history, higher neuroticism and harm avoidance scores.</p></sec><sec><title>Competing interests</title><p>The author(s) declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>G Koller participated in the design of the study and performed the statistical analysis and is writer of the text.</p><p>B Bondy and P Zill carried out the molecular genetic studies</p><p>U Preuss and M Soyka conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lesch</surname><given-names>KP</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Reif</surname><given-names>A</given-names></name><name><surname>Gutknecht</surname><given-names>L</given-names></name></person-group><article-title>Anxiety-related traits in mice with modified genes of the serotonergic pathway</article-title><source>Eur J Pharmacol</source><year>2003</year><volume>7:480</volume><fpage>185</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">14623362</pub-id><pub-id pub-id-type="doi">10.1016/j.ejphar.2003.08.106</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Griebel</surname><given-names>G</given-names></name></person-group><article-title>5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research</article-title><source>Pharmacol Ther</source><year>1995</year><volume>65</volume><fpage>319</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">7644567</pub-id><pub-id pub-id-type="doi">10.1016/0163-7258(95)98597-J</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Griebel</surname><given-names>G</given-names></name></person-group><article-title>Variability in the effects of 5-HT-related compounds in experimental models of anxiety: evidence for multiple mechanisms of 5-HT in anxiety or never ending story?</article-title><source>Pol J Pharmacol</source><year>1996</year><volume>48</volume><fpage>129</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">9112642</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parks</surname><given-names>CL</given-names></name><name><surname>Robinson</surname><given-names>PS</given-names></name><name><surname>Sibille</surname><given-names>E</given-names></name><name><surname>Shenk</surname><given-names>T</given-names></name><name><surname>Toth</surname><given-names>M</given-names></name></person-group><article-title>Increased anxiety of mice lacking the serotonine-1A receptor</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>1,95</volume><fpage>10734</fpage><lpage>10739</lpage><pub-id pub-id-type="pmid">9724773</pub-id><pub-id pub-id-type="doi">10.1073/pnas.95.18.10734</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramboz</surname><given-names>S</given-names></name><name><surname>Oosting</surname><given-names>R</given-names></name><name><surname>Amara</surname><given-names>DA</given-names></name><name><surname>Kung</surname><given-names>HF</given-names></name><name><surname>Blier</surname><given-names>P</given-names></name><name><surname>Mendelsohn</surname><given-names>M</given-names></name><name><surname>Mann</surname><given-names>JJ</given-names></name><name><surname>Brunner</surname><given-names>D</given-names></name><name><surname>Hen</surname><given-names>R</given-names></name></person-group><article-title>Serotonine receptor 1A knockout: an animal model of anxiety-related disorder</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>14476</fpage><lpage>14481</lpage><pub-id pub-id-type="pmid">9826725</pub-id><pub-id pub-id-type="doi">10.1073/pnas.95.24.14476</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olivier</surname><given-names>B</given-names></name><name><surname>Soudijn</surname><given-names>W</given-names></name><name><surname>van Wijingarden</surname><given-names>I</given-names></name></person-group><article-title>The 5HT1A receptor and its ligands: structure and function</article-title><source>Prog Drug Res</source><year>1999</year><volume>52</volume><fpage>103</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">10396127</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>File</surname><given-names>SE</given-names></name><name><surname>Kenny</surname><given-names>PJ</given-names></name><name><surname>Cheeta</surname><given-names>S</given-names></name></person-group><article-title>The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety</article-title><source>Pharmacol Biochem Behav</source><year>2000</year><volume>66</volume><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">10837844</pub-id><pub-id pub-id-type="doi">10.1016/S0091-3057(00)00198-2</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mongeau</surname><given-names>R</given-names></name><name><surname>Blier</surname><given-names>P</given-names></name><name><surname>de Montigny</surname><given-names>C</given-names></name></person-group><article-title>The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments</article-title><source>Brain Res Brain Res Rev</source><year>1997</year><volume>23</volume><fpage>145</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">9164669</pub-id><pub-id pub-id-type="doi">10.1016/S0165-0173(96)00017-3</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pineyro</surname><given-names>G</given-names></name><name><surname>Blier</surname><given-names>P</given-names></name></person-group><article-title>Autoregulation of serotonin neurons: role in antidepressant drug action</article-title><source>Pharmacol Rev</source><year>1999</year><volume>51</volume><fpage>533</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">10471417</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doris</surname><given-names>A</given-names></name><name><surname>Ebmeier</surname><given-names>K</given-names></name><name><surname>Shajan</surname><given-names>P</given-names></name></person-group><article-title>Depressive illness</article-title><source>Lancet</source><volume>354</volume><fpage>1369</fpage><lpage>75</lpage><comment>1999 Oct 16</comment><pub-id pub-id-type="pmid">10533878</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(99)03121-9</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobilka</surname><given-names>BK</given-names></name><name><surname>Frielle</surname><given-names>T</given-names></name><name><surname>Collins</surname><given-names>S</given-names></name><name><surname>Yang-Feng</surname><given-names>T</given-names></name><name><surname>Kobilka</surname><given-names>TS</given-names></name><name><surname>Francke</surname><given-names>U</given-names></name><name><surname>Lefkowitz</surname><given-names>RJ</given-names></name><name><surname>Caron</surname><given-names>MG</given-names></name></person-group><article-title>An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins</article-title><source>Nature</source><year>1987</year><volume>329</volume><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">3041227</pub-id><pub-id pub-id-type="doi">10.1038/329075a0</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lemonde</surname><given-names>S</given-names></name><name><surname>Turecki</surname><given-names>G</given-names></name><name><surname>Bakish</surname><given-names>D</given-names></name><name><surname>Du</surname><given-names>L</given-names></name><name><surname>Hrdina</surname><given-names>PD</given-names></name><name><surname>Bown</surname><given-names>CD</given-names></name><name><surname>Sequeira</surname><given-names>A</given-names></name><name><surname>Kushwaha</surname><given-names>N</given-names></name><name><surname>Morris</surname><given-names>SJ</given-names></name><name><surname>Basak</surname><given-names>A</given-names></name><name><surname>Ou</surname><given-names>XM</given-names></name><name><surname>Albert</surname><given-names>PR</given-names></name></person-group><article-title>Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide</article-title><source>J Neurosci</source><year>2003</year><volume>24:23</volume><fpage>8788</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">14507979</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>UE</given-names></name><name><surname>Hellweg</surname><given-names>R</given-names></name><name><surname>Kalus</surname><given-names>P</given-names></name><name><surname>Bajbouj</surname><given-names>M</given-names></name><name><surname>Lenzen</surname><given-names>KP</given-names></name><name><surname>Sander</surname><given-names>T</given-names></name><name><surname>Kunz</surname><given-names>D</given-names></name><name><surname>Gallinat</surname><given-names>J</given-names></name></person-group><article-title>Association of a functional BDNF polymorphism and anxiety-related personality traits</article-title><source>Psychopharmacology (Berl)</source><year>2005</year><volume>180</volume><fpage>95</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15918078</pub-id><pub-id pub-id-type="doi">10.1007/s00213-004-2137-7</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marijnissen</surname><given-names>G</given-names></name><name><surname>Tuinier</surname><given-names>S</given-names></name><name><surname>Sijben</surname><given-names>AE</given-names></name><name><surname>Verhoeven</surname><given-names>RM</given-names></name></person-group><article-title>The temperament and character inventory in major depression</article-title><source>J Affect Disord</source><year>2002</year><volume>70</volume><fpage>219</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">12117635</pub-id><pub-id pub-id-type="doi">10.1016/S0165-0327(01)00364-0</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strobel</surname><given-names>A</given-names></name><name><surname>Gutknecht</surname><given-names>L</given-names></name><name><surname>Rothe</surname><given-names>C</given-names></name><name><surname>Reif</surname><given-names>A</given-names></name><name><surname>Mossner</surname><given-names>R</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Brocke</surname><given-names>B</given-names></name><name><surname>Lesch</surname><given-names>KP</given-names></name></person-group><article-title>Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits</article-title><source>J Neural Transm</source><year>2003</year><volume>110</volume><fpage>1445</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">14666415</pub-id><pub-id pub-id-type="doi">10.1007/s00702-003-0072-0</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>YY</given-names></name><name><surname>Battistuzzi</surname><given-names>C</given-names></name><name><surname>Oquendo</surname><given-names>MA</given-names></name><name><surname>Harkavy-Friedman</surname><given-names>J</given-names></name><name><surname>Greenhill</surname><given-names>L</given-names></name><name><surname>Zalsman</surname><given-names>G</given-names></name><name><surname>Brodsky</surname><given-names>B</given-names></name><name><surname>Arango</surname><given-names>V</given-names></name><name><surname>Brent</surname><given-names>DA</given-names></name><name><surname>Mann</surname><given-names>JJ</given-names></name></person-group><article-title>Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology</article-title><source>Int J Neuropsychopharmacol</source><year>2004</year><volume>7</volume><fpage>441</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">15469667</pub-id><pub-id pub-id-type="doi">10.1017/S1461145704004663</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krystal</surname><given-names>JH</given-names></name><name><surname>Webb</surname><given-names>E</given-names></name><name><surname>Cooney</surname><given-names>NL</given-names></name><name><surname>Kranzler</surname><given-names>HR</given-names></name><name><surname>Southwick</surname><given-names>SW</given-names></name><name><surname>Heninger</surname><given-names>GR</given-names></name><name><surname>Charney</surname><given-names>DS</given-names></name></person-group><article-title>Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects</article-title><source>Am J Psychiatry</source><year>1996</year><volume>153</volume><fpage>83</fpage><pub-id pub-id-type="pmid">8540598</pub-id></citation></ref><ref id="B18"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Wittchen</surname><given-names>HU</given-names></name><name><surname>Fydrich</surname><given-names>T</given-names></name></person-group><article-title>Strukturiertes klinisches Interview f&#x000fc;r DSM-IV, Manual zu SKID-I und SKID-II, G&#x000f6;ttingen: Hogrefe</article-title></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bucholz</surname><given-names>KK</given-names></name><name><surname>Cadoret</surname><given-names>R</given-names></name><name><surname>Cloninger</surname><given-names>CR</given-names></name><name><surname>Dinwiddie</surname><given-names>SH</given-names></name><name><surname>Hesselbrock</surname><given-names>VM</given-names></name><name><surname>Nurnberger</surname><given-names>JI</given-names></name><name><surname>Reich</surname><given-names>T</given-names></name><name><surname>Schmidt</surname><given-names>I</given-names></name><name><surname>Schuckit</surname><given-names>MA</given-names></name></person-group><article-title>A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA</article-title><source>J Stud Alcohol</source><year>1995</year><volume>55</volume><fpage>149</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">8189735</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hesselbrock</surname><given-names>M</given-names></name><name><surname>Easton</surname><given-names>C</given-names></name><name><surname>Bucholz</surname><given-names>KK</given-names></name><name><surname>Schuckit</surname><given-names>M</given-names></name><name><surname>Hesselbrock</surname><given-names>V</given-names></name></person-group><article-title>A validity study of the SSAGA a comparison with the SCAN</article-title><source>Addiction</source><year>1999</year><volume>94</volume><fpage>1361</fpage><lpage>1370</lpage><pub-id pub-id-type="pmid">10615721</pub-id><pub-id pub-id-type="doi">10.1046/j.1360-0443.1999.94913618.x</pub-id></citation></ref><ref id="B21"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Borkenau</surname><given-names>P</given-names></name><name><surname>Ostendorf</surname><given-names>F</given-names></name></person-group><source>Das NEO -F&#x000fc;nf Faktoren Inventar (NEOFFI), G&#x000f6;ttingen, Hogrefe</source><year>1994</year></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>J</given-names></name><name><surname>Eisemann</surname><given-names>M</given-names></name><name><surname>Richter</surname><given-names>G</given-names></name></person-group><article-title>Die deutschsprachigen Version des Temperament- und Charakterinventars (TCI)</article-title><source>Zeitschrift f Klin Psychol und Psychother</source><year>2000</year><volume>29</volume><fpage>117</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1026//0084-5345.29.2.117</pub-id></citation></ref><ref id="B23"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Weyers</surname><given-names>P</given-names></name><name><surname>Krebs</surname><given-names>H</given-names></name><name><surname>Janke</surname><given-names>W</given-names></name></person-group><article-title>Reliability and construct reliability of a german version of Cloninger's Tridimensional personality questionnaire, Personality and individual differences</article-title><year>1995</year><volume>19</volume><fpage>853</fpage><lpage>861</lpage></citation></ref><ref id="B24"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Cloninger</surname><given-names>CR</given-names></name><name><surname>Przybeck</surname><given-names>TR</given-names></name><name><surname>Svrakic</surname><given-names>DM</given-names></name><name><surname>Wetzel</surname><given-names>R</given-names></name></person-group><source>The temperament and character inventory (TCI) a guide to its development and use</source><year>1994</year><publisher-name>St. Louis, Washington University school of Medicine, Department of psychiatry</publisher-name></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koller</surname><given-names>G</given-names></name><name><surname>Bondy</surname><given-names>B</given-names></name><name><surname>Preuss</surname><given-names>UW</given-names></name><name><surname>Bottlender</surname><given-names>M</given-names></name><name><surname>Soyka</surname><given-names>M</given-names></name></person-group><article-title>No association between a polymorphism in the promoter region of the MAOA gene with antisocial personality traits in alcoholics</article-title><source>Alcohol Alcohol</source><year>2003</year><volume>38</volume><fpage>31</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">12554604</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soyka</surname><given-names>M</given-names></name><name><surname>Preuss</surname><given-names>U</given-names></name><name><surname>Koller</surname><given-names>G</given-names></name><name><surname>Zill</surname><given-names>P</given-names></name><name><surname>Bondy</surname><given-names>B</given-names></name></person-group><article-title>Dopamine D4 receptor polymorphism in extraversion revisited: Results from the Munich Gene Bank Project for alcoholism</article-title><source>Psychiatry Res</source><year>2002</year><volume>36</volume><fpage>429</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/S0022-3956(02)00049-3</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Babor</surname><given-names>TF</given-names></name><name><surname>Hofman</surname><given-names>M</given-names></name><name><surname>DelBoca</surname><given-names>FK</given-names></name><name><surname>Hesselbrock</surname><given-names>VM</given-names></name><name><surname>Meyer</surname><given-names>RE</given-names></name><name><surname>Dolinsky</surname><given-names>CS</given-names></name><name><surname>Rounsaville</surname><given-names>BJ</given-names></name></person-group><article-title>Types of alcoholics: Evidence for an empirically derived typology based on indicators of vulnerability and severity</article-title><source>Arch Gen Psychiatry</source><year>1992</year><volume>49</volume><fpage>599</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">1637250</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schuckit</surname><given-names>MA</given-names></name><name><surname>Tipp</surname><given-names>JE</given-names></name><name><surname>Smith</surname><given-names>TL</given-names></name><name><surname>Shapiro</surname><given-names>E</given-names></name><name><surname>Hesselbrock</surname><given-names>VM</given-names></name><name><surname>Bucholz</surname><given-names>KK</given-names></name><name><surname>Reich</surname><given-names>T</given-names></name><name><surname>Nurnberger</surname><given-names>JL</given-names></name></person-group><article-title>An evaluation of type A and type B alcoholics</article-title><source>Addiction</source><year>1995</year><volume>90</volume><fpage>1189</fpage><lpage>1203</lpage><pub-id pub-id-type="pmid">7580817</pub-id><pub-id pub-id-type="doi">10.1111/j.1360-0443.1995.tb01089.x</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Toyota</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>A</given-names></name><name><surname>Shibuya</surname><given-names>H</given-names></name><name><surname>Nankai</surname><given-names>M</given-names></name><name><surname>Hattori</surname><given-names>E</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Kurumaji</surname><given-names>A</given-names></name><name><surname>Karkera</surname><given-names>JD</given-names></name><name><surname>Detera-Wadleigh</surname><given-names>SD</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name></person-group><article-title>Association study on the DUSP6 gene, an affective disorder candidate gene on 12q23, performed by using fluorescence resonance energy transfer-based melting curve analysis on the LightCycler</article-title><source>Mol Psychiatry</source><year>2000</year><volume>5</volume><fpage>489</fpage><lpage>494</lpage><pub-id pub-id-type="pmid">11035444</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4000748</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Svrakic</surname><given-names>DM</given-names></name><name><surname>Draganic</surname><given-names>M</given-names></name><name><surname>Hill</surname><given-names>K</given-names></name><name><surname>Bayon</surname><given-names>C</given-names></name><name><surname>Przybeck</surname><given-names>TR</given-names></name><name><surname>Cloninger</surname><given-names>CR</given-names></name></person-group><article-title>Temperament, Character and personality disorders: etiologic, diagnostic, treatment issues</article-title><source>Acta Psychiatr Scand</source><year>2002</year><volume>106</volume><fpage>189</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">12197856</pub-id><pub-id pub-id-type="doi">10.1034/j.1600-0447.2002.02196.x</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>J</given-names></name><name><surname>Perez</surname><given-names>S</given-names></name><name><surname>Oficialdegui</surname><given-names>AM</given-names></name><name><surname>Heras</surname><given-names>B</given-names></name><name><surname>Orus</surname><given-names>L</given-names></name><name><surname>Villanueva</surname><given-names>H</given-names></name><name><surname>Palop</surname><given-names>JA</given-names></name><name><surname>Roca</surname><given-names>J</given-names></name><name><surname>Mourelle</surname><given-names>M</given-names></name><name><surname>Bosch</surname><given-names>A</given-names></name><name><surname>Del Castillo</surname><given-names>JC</given-names></name><name><surname>Lasheras</surname><given-names>B</given-names></name><name><surname>Tordera</surname><given-names>R</given-names></name><name><surname>del Rio</surname><given-names>J</given-names></name><name><surname>Monge</surname><given-names>A</given-names></name></person-group><article-title>New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants</article-title><source>Eur J Med Chem</source><year>2001</year><volume>36</volume><fpage>55</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">11231049</pub-id><pub-id pub-id-type="doi">10.1016/S0223-5234(00)01198-3</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munafo</surname><given-names>MR</given-names></name><name><surname>Clark</surname><given-names>T</given-names></name><name><surname>Flint</surname><given-names>J</given-names></name></person-group><article-title>Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits?</article-title><source>A meta-analysis Mol Psychiatry</source><year>2005</year><volume>10</volume><fpage>415</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/sj.mp.4001627</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schinka</surname><given-names>JA</given-names></name><name><surname>Busch</surname><given-names>RM</given-names></name><name><surname>Robichaux-Keene</surname><given-names>N</given-names></name></person-group><article-title>A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety</article-title><source>Mol Psychiatry</source><year>2004</year><volume>9</volume><fpage>197</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">14966478</pub-id><pub-id pub-id-type="doi">10.1038/sj.mp.4001405</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>SP</given-names></name><name><surname>Murthy</surname><given-names>NY</given-names></name><name><surname>Rabiner</surname><given-names>EA</given-names></name><name><surname>Munafo</surname><given-names>MR</given-names></name><name><surname>Johnstone</surname><given-names>EC</given-names></name><name><surname>Jacob</surname><given-names>R</given-names></name><name><surname>Walton</surname><given-names>RT</given-names></name><name><surname>Grasby</surname><given-names>PM</given-names></name></person-group><article-title>A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans</article-title><source>J Neurosci</source><volume>25</volume><fpage>2586</fpage><lpage>90</lpage><comment>2005 Mar 9</comment><pub-id pub-id-type="pmid">15758168</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3769-04.2005</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lesch</surname><given-names>KP</given-names></name><name><surname>Wiesmann</surname><given-names>M</given-names></name><name><surname>Hoh</surname><given-names>A</given-names></name><name><surname>Muller</surname><given-names>T</given-names></name><name><surname>Disselkamp-Tietze</surname><given-names>J</given-names></name><name><surname>Osterheider</surname><given-names>M</given-names></name><name><surname>Schulte</surname><given-names>HM</given-names></name></person-group><article-title>5-HT1A receptor-effector system responsivity in panic disorder</article-title><source>Psychopharmacology (Berl)</source><year>1992</year><volume>106</volume><fpage>111</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1346719</pub-id><pub-id pub-id-type="doi">10.1007/BF02253597</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rothe</surname><given-names>C</given-names></name><name><surname>Gutknecht</surname><given-names>L</given-names></name><name><surname>Freitag</surname><given-names>C</given-names></name><name><surname>Tauber</surname><given-names>R</given-names></name><name><surname>Mossner</surname><given-names>R</given-names></name><name><surname>Franke</surname><given-names>P</given-names></name><name><surname>Fritze</surname><given-names>J</given-names></name><name><surname>Wagner</surname><given-names>G</given-names></name><name><surname>Peikert</surname><given-names>G</given-names></name><name><surname>Wenda</surname><given-names>B</given-names></name><name><surname>Sand</surname><given-names>P</given-names></name><name><surname>Jacob</surname><given-names>C</given-names></name><name><surname>Rietschel</surname><given-names>M</given-names></name><name><surname>Nothen</surname><given-names>MM</given-names></name><name><surname>Garritsen</surname><given-names>H</given-names></name><name><surname>Fimmers</surname><given-names>R</given-names></name><name><surname>Deckert</surname><given-names>J</given-names></name><name><surname>Lesch</surname><given-names>KP</given-names></name></person-group><article-title>Association of a functional 1019C&#x0003e;G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia</article-title><source>Int J Neuropsychopharmacol</source><year>2004</year><volume>7</volume><fpage>189</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">14984628</pub-id><pub-id pub-id-type="doi">10.1017/S1461145703004061</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drevets</surname><given-names>WC</given-names></name><name><surname>Frank</surname><given-names>E</given-names></name><name><surname>Price</surname><given-names>JC</given-names></name><name><surname>Kupfer</surname><given-names>DJ</given-names></name><name><surname>Holt</surname><given-names>D</given-names></name><name><surname>Greer</surname><given-names>PJ</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Gautier</surname><given-names>C</given-names></name><name><surname>Mathis</surname><given-names>C</given-names></name></person-group><article-title>PET imaging of serotonin 1A receptor binding in depression</article-title><source>Biol Psychiatry</source><year>1999</year><volume>15;46</volume><fpage>1375</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">10578452</pub-id><pub-id pub-id-type="doi">10.1016/S0006-3223(99)00189-4</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishiguchi</surname><given-names>N</given-names></name><name><surname>Shirakawa</surname><given-names>O</given-names></name><name><surname>Ono</surname><given-names>H</given-names></name><name><surname>Nishimura</surname><given-names>A</given-names></name><name><surname>Nushida</surname><given-names>H</given-names></name><name><surname>Ueno</surname><given-names>Y</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name></person-group><article-title>Lack of an association between 5-HT1A receptor gene structural polymorphisms and suicide victims</article-title><source>Am J Med Genet</source><year>2002</year><volume>8:114</volume><fpage>423</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11992564</pub-id><pub-id pub-id-type="doi">10.1002/ajmg.10414</pub-id></citation></ref></ref-list></back></article> 